The human plasma-metabolome: Reference values in 800 French healthy volunteers; impact of cholesterol, gender and age

Séverine Trabado, Abdallah Al-Salameh, Vincent Croixmarie, Perrine Masson, Emmanuelle Corruble, Bruno Fève, Romain Colle, Laurent Ripoll, Bernard Walther, Claire Boursier-Neyret, Erwan Werner, Laurent Becquemont, Philippe Chanson, Séverine Trabado, Abdallah Al-Salameh, Vincent Croixmarie, Perrine Masson, Emmanuelle Corruble, Bruno Fève, Romain Colle, Laurent Ripoll, Bernard Walther, Claire Boursier-Neyret, Erwan Werner, Laurent Becquemont, Philippe Chanson

Abstract

Metabolomic approaches are increasingly used to identify new disease biomarkers, yet normal values of many plasma metabolites remain poorly defined. The aim of this study was to define the "normal" metabolome in healthy volunteers. We included 800 French volunteers aged between 18 and 86, equally distributed according to sex, free of any medication and considered healthy on the basis of their medical history, clinical examination and standard laboratory tests. We quantified 185 plasma metabolites, including amino acids, biogenic amines, acylcarnitines, phosphatidylcholines, sphingomyelins and hexose, using tandem mass spectrometry with the Biocrates AbsoluteIDQ p180 kit. Principal components analysis was applied to identify the main factors responsible for metabolome variability and orthogonal projection to latent structures analysis was employed to confirm the observed patterns and identify pattern-related metabolites. We established a plasma metabolite reference dataset for 144/185 metabolites. Total blood cholesterol, gender and age were identified as the principal factors explaining metabolome variability. High total blood cholesterol levels were associated with higher plasma sphingomyelins and phosphatidylcholines concentrations. Compared to women, men had higher concentrations of creatinine, branched-chain amino acids and lysophosphatidylcholines, and lower concentrations of sphingomyelins and phosphatidylcholines. Elderly healthy subjects had higher sphingomyelins and phosphatidylcholines plasma levels than young subjects. We established reference human metabolome values in a large and well-defined population of French healthy volunteers. This study provides an essential baseline for defining the "normal" metabolome and its main sources of variation.

Conflict of interest statement

Competing Interests: One or more of the authors are employed by a commercial company: "Technologie Servier", [VC, PM, LR, BW, CBN, EW]. These authors don’t have any conflict of interest. This commercial affiliation does not alter our adherence to all PLOS ONE policies on sharing data and materials.

Figures

Fig 1. Scores plot from PCA multivariate…
Fig 1. Scores plot from PCA multivariate analyses: PC1 vs. PC2 scores plot from PCA of metabolic profiles, colored according to (A) Total Blood Cholesterol, (B) Gender, (C) Age.
(A) Total Blood Cholesterol. Clinically relevant limits have been set on the TBC concentrations; the red dots (HVs with TBC above 6.2 mmol/L) are on the right, the green dots (HVs with TBC below 5.1 mmol/L) are over-represented on the left, and the yellow dots are in-between. (B) Gender. Clouds of red dots (Females) are mainly represented on the upper side of the PC2, while blue dots (Males) are mainly represented on the lower side of the PC2. (C) Age. Each age group is represented in different colors, from blue to red; an aging trend is seen along PC1.
Fig 2. Correlation of TBC with metabolome…
Fig 2. Correlation of TBC with metabolome values in healthy volunteers.
(A) Scores plot from OPLS multivariate analysis, cross-validated score plot resulting from OPLS modeling of Total Blood Cholesterol. Clinically relevant limits have been set on the TBC concentrations; the red dots represent HVs with TBC above 6.2 mmol/L, the green dots, HVs with TBC below 5.1 mmol/L, and the yellow dots are in-between. (B) TBC S-plot. Metabolites in the upper right corner correlate positively with total blood cholesterol. The p axis describes the contribution of each variable to the model. (C) Total phosphatidylcholines concentration according to total blood cholesterol. TBC below 5.1 mmol/L (green), between 5.11 and 6.2 mmol/L (orange) and above 6.21 mmol/L (red). (D) Total sphingomyelins concentration according to total blood cholesterol. (E) Phospholipase activity according to total blood cholesterol. ** p<0.01;***p<0.001.
Fig 3. Gender effect on the metabolic…
Fig 3. Gender effect on the metabolic profile of healthy volunteers.
(A) Scores plot from OPLS multivariate analysis, cross-validated score plot resulting from OPLS modeling of gender. Females are represented with red dots, males with blue dots. (B) Gender S-Plot. Metabolites in the upper-right corner are higher in women; those in the lower-left corner are higher in males. The p axis describes the contribution of each variable to the model. (C) Total sphingomyelins concentration according to sex. (D) Total lysophosphatidylcholines concentration according to sex. (E) Phospholipase activity according to sex. ***p<0.001.
Fig 4. Age effect on the metabolite…
Fig 4. Age effect on the metabolite profile of healthy volunteers.
(A) Scores plot from OPLS multivariate analysis, cross-validated score plot resulting from OPLS modeling of age. Each age group is represented in different colors, from blue to red. (B) Age S-plot. Metabolites in the upper-right corner correlate positively with age, while those in the bottom-left corner correlate negatively with age. The p axis describes the contribution of each variable to the model. (C) Total sphingomyelins concentration according to the age group. (D) Total phosphatidylcholines concentration according to the age group. (E) Phospholipase activity according to the age group. *p<0.05; ** p<0.01; ***p<0.001.

References

    1. Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev. 2011. January;40(1):387–426. 10.1039/b906712b
    1. Psychogios N, Hau DD, Peng J, Guo AC, Mandal R, Bouatra S, et al. The human serum metabolome. PLoS One. 2011;6(2):e16957 10.1371/journal.pone.0016957
    1. Bub A, Kriebel A, Dörr C, Bandt S, Rist M, Roth A, et al. The Karlsruhe Metabolomics and Nutrition (KarMeN) Study: Protocol and Methods of a Cross-Sectional Study to Characterize the Metabolome of Healthy Men and Women. JMIR Res Protoc. 2016. July 15;5(3):e146 10.2196/resprot.5792
    1. Shin SY, Petersen AK, Wahl S, Zhai G, Romisch-Margl W, Small KS, et al. Interrogating causal pathways linking genetic variants, small molecule metabolites, and circulating lipids. Genome Med. 2014;6(3):25 10.1186/gm542
    1. Krug S, Kastenmuller G, Stuckler F, Rist MJ, Skurk T, Sailer M, et al. The dynamic range of the human metabolome revealed by challenges. Faseb J. 2012. June;26(6):2607–19. 10.1096/fj.11-198093
    1. Floegel A, Drogan D, Wang-Sattler R, Prehn C, Illig T, Adamski J, et al. Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach. PLoS One. 2011;6(6):e21103 10.1371/journal.pone.0021103
    1. Breier M, Wahl S, Prehn C, Fugmann M, Ferrari U, Weise M, et al. Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples. PLoS One. 2014;9(2):e89728 10.1371/journal.pone.0089728
    1. The Human Metabolome Database. ; [cited 2017 February].
    1. Chanson P, Arnoux A, Mavromati M, Brailly-Tabard S, Massart C, Young J, et al. Reference values for insulin-like growth factor I (IGF-I) serum concentrations: comparison of six immunoassays. J Clin Endocrinol Metab. 2016. May 11:jc20161257.
    1. Dunn WB, Lin W, Broadhurst D, Begley P, Brown M, Zelena E, et al. Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics. 2015;11:9–26. 10.1007/s11306-014-0707-1
    1. Yet I, Menni C, Shin SY, Mangino M, Soranzo N, Adamski J, et al. Genetic Influences on Metabolite Levels: A Comparison across Metabolomic Platforms. PLoS One. 2016. April 13;11(4).
    1. Carayol M, Licaj I, Achaintre D, Sacerdote C, Vineis P, Key TJ, et al. Reliability of Serum Metabolites over a Two-Year Period: A Targeted Metabolomic Approach in Fasting and Non-Fasting Samples from EPIC. PLoS One. 2015. August 14;10(8).
    1. Nicholson JK, Everett JR, Lindon JC. Longitudinal pharmacometabonomics for predicting patient responses to therapy: drug metabolism, toxicity and efficacy. Expert Opin Drug Metab Toxicol. 2012. February;8(2):135–9. 10.1517/17425255.2012.646987
    1. Everett JR. From Metabonomics to Pharmacometabonomics: The Role of Metabolic Profiling in Personalized Medicine. Front Pharmacol. 2016;7:297 10.3389/fphar.2016.00297
    1. Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010. November;51(11):3299–305. 10.1194/jlr.M009449
    1. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science. 1972. February 18;175(4023):720–31.
    1. Furse S, de Kroon AIPM. Phosphatidylcholine's functions beyond that of a membrane brick. Mol Membr Biol. 2015. May 19;32(4):117–9. 10.3109/09687688.2015.1066894
    1. Chakravarthy MV, Lodhi IJ, Yin L, Malapaka RRV, Xu HE, Turk J, et al. Identification of a Physiologically Relevant Endogenous Ligand for PPAR alpha in Liver. Cell. 2009. August 7;138(3):476–88. 10.1016/j.cell.2009.05.036
    1. Kersten S. Integrated physiology and systems biology of PPAR alpha. Mol Metab. 2014. July;3(4):354–71. 10.1016/j.molmet.2014.02.002
    1. Ersoy BA, Tarun A, D'Aquino K, Hancer NJ, Ukomadu C, White MF, et al. Phosphatidylcholine Transfer Protein Interacts with Thioesterase Superfamily Member 2 to Attenuate Insulin Signaling. Sci Signal. 2013. July 30;6(286).
    1. Sakai H, Kado S, Taketomi A, Sakane F. Diacylglycerol Kinase delta Phosphorylates Phosphatidylcholine-specific Phospholipase C-dependent, Palmitic Acid-containing Diacylglycerol Species in Response to High Glucose Levels. J Biol Chem. 2014. September 19;289(38):26607–17. 10.1074/jbc.M114.590950
    1. Wirtz KWA. Phospholipid Transfer Proteins. Annu Rev Biochem. 1991;60:73–99. 10.1146/annurev.bi.60.070191.000445
    1. de Brouwer APM, Westerman J, Kleinnijenhuis A, Bevers LE, Roelofsen B, Wirtz KWA. Clofibrate-induced relocation of phosphatidylcholine transfer protein to mitochondria in endothelial cells. Exp Cell Res. 2002. March 10;274(1):100–11. 10.1006/excr.2001.5460
    1. Roderick SL, Chan WW, Agate DS, Olsen LR, Vetting MW, Rajashankar KR, et al. Structure of human phosphatidylcholine transfer protein in complex with its ligand. Nat Struct Biol. 2002. July;9(7):507–11. 10.1038/nsb812
    1. Mittelstrass K, Ried JS, Yu Z, Krumsiek J, Gieger C, Prehn C, et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 2011. August;7(8):e1002215 10.1371/journal.pgen.1002215
    1. Krumsiek J, Mittelstrass K, Do KT, Stuckler F, Ried J, Adamski J, et al. Gender-specific pathway differences in the human serum metabolome. Metabolomics. 2015;11(6):1815–33. 10.1007/s11306-015-0829-0
    1. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem. 1992. October;38(10):1933–53.
    1. Armstrong MD, Stave U. A study of plasma free amino acid levels. II. Normal values for children and adults. Metabolism. 1973. April;22(4):561–9.
    1. Reuter SE, Evans AM, Chace DH, Fornasini G. Determination of the reference range of endogenous plasma carnitines in healthy adults. Ann Clin Biochem. 2008. November;45(Pt 6):585–92. 10.1258/acb.2008.008045
    1. Ishikawa M, Maekawa K, Saito K, Senoo Y, Urata M, Murayama M, et al. Plasma and serum lipidomics of healthy white adults shows characteristic profiles by subjects' gender and age. PLoS One. 2014;9(3):e91806 10.1371/journal.pone.0091806
    1. Merrill AH, Wang E, Innis WSA, Mullins R. Increases in Serum Sphingomyelin by 17 Beta-Estradiol. Lipids. 1985;20(4):252–4.
    1. Nikkila J, Sysi-Aho M, Ermolov A, Seppanen-Laakso T, Simell O, Kaski S, et al. Gender-dependent progression of systemic metabolic states in early childhood. Mol Syst Biol. 2008;4:197 10.1038/msb.2008.34
    1. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev. 2008. June;29(4):381–402. 10.1210/er.2007-0025
    1. Yeboah J, McNamara C, Jiang XC, Tabas I, Herrington DM, Burke GL, et al. Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol. 2010. March;30(3):628–33. 10.1161/ATVBAHA.109.199281
    1. Yu Z, Zhai G, Singmann P, He Y, Xu T, Prehn C, et al. Human serum metabolic profiles are age dependent. Aging Cell. 2012. December;11(6):960–7. 10.1111/j.1474-9726.2012.00865.x
    1. Mielke MM, Bandaru VVR, Han DF, An Y, Resnick SM, Ferrucci L, et al. Factors affecting longitudinal trajectories of plasma sphingomyelins: the Baltimore Longitudinal Study of Aging. Aging Cell. 2015. February;14(1):112–21. 10.1111/acel.12275
    1. Matsumoto T, Kobayashi T, Kamata K. Role of lysophosphatidylcholine (LPC) in atherosclerosis. Curr Med Chem. 2007;14(30):3209–20.
    1. van Meer G, de Kroon AI. Lipid map of the mammalian cell. J Cell Sci. 2011. January 1;124(Pt 1):5–8. 10.1242/jcs.071233
    1. Mecocci P, Cherubini A, Beal MF, Cecchetti R, Chionne F, Polidori MC, et al. Altered mitochondrial membrane fluidity in AD brain. Neurosci Lett. 1996. March 29;207(2):129–32.
    1. Sprong H, van der Sluijs P, van Meer G. How proteins move lipids and lipids move proteins. Nat Rev Mol Cell Biol. 2001. July;2(7):504–13. 10.1038/35080071
    1. Ichi I, Kamikawa C, Nakagawa T, Kobayashi K, Kataoka R, Nagata E, et al. Neutral sphingomyelinase-induced ceramide accumulation by oxidative stress during carbon tetrachloride intoxication. Toxicology. 2009. June 30;261(1–2):33–40. 10.1016/j.tox.2009.04.040
    1. Corre I, Niaudet C, Paris F. Plasma membrane signaling induced by ionizing radiation. Mutat Res-Rev Mutat. 2010. Apr-Jun;704(1–3):61–7.
    1. Clement AB, Gamerdinger M, Tamboli IY, Lutjohann D, Walter J, Greeve I, et al. Adaptation of neuronal cells to chronic oxidative stress is associated with altered cholesterol and sphingolipid homeostasis and lysosomal function. J Neurochem. 2009. November;111(3):669–82. 10.1111/j.1471-4159.2009.06360.x
    1. Piccinini M, Scandroglio F, Prioni S, Buccinna B, Loberto N, Aureli M, et al. Deregulated sphingolipid metabolism and membrane organization in neurodegenerative disorders. Mol Neurobiol. 2010. June;41(2–3):314–40. 10.1007/s12035-009-8096-6
    1. Nelson JC, Jiang XC, Tabas I, Tall A, Shea S. Plasma sphingomyelin and subclinical atherosclerosis: findings from the multi-ethnic study of atherosclerosis. Am J Epidemiol. 2006. May 15;163(10):903–12. 10.1093/aje/kwj140
    1. Smith AR, Visioli F, Frei B, Hagen TM. Age-related changes in endothelial nitric oxide synthase phosphorylation and nitric oxide dependent vasodilation: evidence for a novel mechanism involving sphingomyelinase and ceramide-activated phosphatase 2A. Aging Cell. 2006. October;5(5):391–400. 10.1111/j.1474-9726.2006.00232.x
    1. Gonzalez-Covarrubias V, Beekman M, Uh HW, Dane A, Troost J, Paliukhovich I, et al. Lipidomics of familial longevity. Aging Cell. 2013. June;12(3):426–34. 10.1111/acel.12064
    1. Vaarhorst AAM, Beekman M, Suchiman EHD, van Heemst D, Houwing-Duistermaat JJ, Westendorp RGJ, et al. Lipid metabolism in long-lived families: the Leiden Longevity Study. Age. 2011. June;33(2):219–27. 10.1007/s11357-010-9172-6
    1. Draisma HHM, Pool R, Kobl M, Jansen R, Petersen AK, Vaarhorst AAM, et al. Genome-wide association study identifies novel genetic variants contributing to variation in blood metabolite levels. Nat Commun. 2015. June;6.
    1. Bouchard-Mercier A, Rudkowska I, Lemieux S, Couture P, Vohl MC. The metabolic signature associated with the Western dietary pattern: a cross-sectional study. Nutr J. 2013. December 11;12.
    1. Souberbielle JC, Massart C, Brailly-Tabard S, Cavalier E, Chanson P. Prevalence and determinants of vitamin D deficiency in healthy French adults: the VARIETE study. Endocrine. 2016. August;53(2):543–50. 10.1007/s12020-016-0960-3
    1. Guertin KA, Moore SC, Sampson JN, Huang WY, Xiao Q, Stolzenberg-Solomon RZ, et al. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. American Journal of Clinical Nutrition. 2014. July;100(1):208–17. 10.3945/ajcn.113.078758

Source: PubMed

3
Předplatit